ArticleBMJ open2026

Efficacy and safety of mycophenolate mofetil in preventing relapse of IgG4-related disease with re-elevation of serum IgG4 level during maintenance therapy: a protocol for a multicentre, randomised, double-blind, placebo-controlled study in China.

Jialei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.